Helping entrepreneurs build tomorrow’s life science companies.
Employees: 1-10
Portfolio 17
| Date | Name | Website | Total Raised | Location |
| 22.06.2023 | PharmEnabl... | pharmenabl... | $9.99M | United Kin... |
| 07.10.2021 | Sola | sola-bio.c... | - | - |
| 20.07.2021 | EditForce ... | editforce.... | - | - |
| - | Ribometrix... | ribometrix... | $45.3M | United Sta... |
| - | QurAlis | quralis.co... | $135.5M | United Sta... |
| - | Corporate ... | miragenthe... | $49.5M | - |
| - | Blacksmith... | blacksmith... | $3.3M | - |
| - | Korro Bio,... | korrobio.c... | $207.5M | United Sta... |
| - | » English | liberother... | - | - |
| - | MyCartis | mycartis.n... | - | Belgium, E... |
Show more
News 77
Show more
Mentions in press and media 12
| Date | Title | Description | Source |
| 10.11.2015 | Daily funding roundup - November 10, 2015 Early-Stage Ventu... | Careem secured $60M; Transfix raised $12M; Spiro closed $1.5M Trucking remains the most widely used ... | vator.tv/n... |
| 24.03.2014 | Emerging sources of early-stage life science funding embrace... | “The biggest challenge for the pharmaceutical company is actually coming up with a product that work... | medcitynew... |
| 09.12.2013 | Covagen Secures CHF 42 Million in Series B Financing | startuptic... | |
| 25.10.2012 | Thrasos Therapeutics Completes $35M Financing | Thrasos Therapeutics, a Montreal, QC, Canada-based clinical stage, biotherapeutics company focused o... | finsmes.co... |
| 20.02.2012 | Are new life science investors eyeing Research Triangle Park... | Plus, the recent CED Life Science Conference had a series of new investor faces in the audience, as ... | medcitynew... |
| 05.01.2012 | Syndexa Pharmaceuticals Raises Series B1 funding from MP Hea... | Syndexa Pharmaceuticals Corp., a Watertown, MA-based biopharmaceutical company developing drugs to t... | finsmes.co... |
| 05.01.2012 | Syndexa Pharma Expands Series B1 Round | WATERTOWN, MA, Biopharmaceutical company developing first-in-class drugs to treat metabolic diseas... | vcnewsdail... |
| 19.11.2009 | Ghent, Belgium-based Pronota Raises €1.3M in Series B financ... | Pronota NV, a Ghent, Belgium-based developer of rationally discovered protein biomarker diagnostics,... | finsmes.co... |
| 07.01.2009 | Intradigm closes $21.4M for cancer therapeutics | Biotech firm Intradigm has tacked an additional $2.9 million onto its second round of funding, bring... | venturebea... |
| 03.10.2008 | Intradigm lands $18.5M to advance oncology treatment | Intradigm, a biotech company that develops RNA interference treatments for cancer, announced today t... | venturebea... |
Show more